1. Home
  2. LPG vs NBTX Comparison

LPG vs NBTX Comparison

Compare LPG & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dorian LPG Ltd.

LPG

Dorian LPG Ltd.

HOLD

Current Price

$43.77

Market Cap

1.8B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$39.53

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPG
NBTX
Founded
2013
2003
Country
United States
France
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
LPG
NBTX
Price
$43.77
$39.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$39.33
$36.00
AVG Volume (30 Days)
605.2K
115.0K
Earning Date
05-21-2026
03-31-2026
Dividend Yield
8.26%
N/A
EPS Growth
112.15
N/A
EPS
4.54
N/A
Revenue
$481,511,242.00
N/A
Revenue This Year
$35.73
$58.17
Revenue Next Year
N/A
N/A
P/E Ratio
$10.12
N/A
Revenue Growth
36.27
N/A
52 Week Low
$23.76
$6.90
52 Week High
$48.12
$57.14

Technical Indicators

Market Signals
Indicator
LPG
NBTX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
LPG
NBTX

About LPG Dorian LPG Ltd.

Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: